NEW YORK, August 21, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding National Oilwell Varco, Inc. (NYSE: NOV), E. I. du Pont de Nemours and Company (NYSE: DD), Nucor Corporation (NYSE: NUE), Philip Morris International, Inc. (NYSE: PM) and Mondelez International, Inc. (NASDAQ: MDLZ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5881-100free.
National Oilwell Varco, Inc. Research Reports
On August 18, 2014, National Oilwell Varco, Inc. (National Oilwell) announced that its Executive Vice President, General Counsel and Secretary, Dwight W. Rettig, intends to retire effective October 1, 2014, The Company informed that it has chosen Craig L. Weinstock as Mr. Rettig's successor. National Oilwell informed that Mr. Weinstock joined the Company in October 2013 as Vice President, Chief Compliance Officer and Vice President of Internal Audit. According to the Company, prior to joining National Oilwell, Mr. Weinstock practiced law at Locke Lord, LLP in Texas for 29 years, counseling corporate boards and independent directors regarding governance, securities and compliance matters. Clay C. Williams, Chairman, President and CEO of National Oilwell commented, "Craig's legal skills, expertise and leadership capabilities make him a natural choice for the role. We are confident that Craig will continue to build our strong, worldwide legal team and provide sound counsel and advice as he has for years." The full research reports on National Oilwell are available to download free of charge at:
http://www.analystsreview.com/Aug-21-2014/NOV/report.pdf
E. I. du Pont de Nemours and Company Research Reports
On August 1, 2014, E. I. du Pont de Nemours and Company (DuPont) announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its Board of Directors, effective October 22, 2014. Commenting on the election, DuPont's Chair and CEO, Ellen Kullman said, "Mark leads a significant global healthcare business and brings strong operating and international experience, including valuable perspective in emerging markets. He will be a strong asset to DuPont as we continue to advance our strategy and bring the strength of our science to bear on some of the world's most pressing challenges." According to the Company, since 2003 Mr. Schneider has served as President and CEO for Fresenius SE & Co. KGaA, a diversified global health care group, with $27.0 billion in revenue in 2013. The full research reports on DuPont are available to download free of charge at:
http://www.analystsreview.com/Aug-21-2014/DD/report.pdf
Nucor Corporation Research Reports
On August 1, 2014, Nucor Corporation (Nucor) announced that Keith Grass, Nucor's Executive Vice President of Raw Materials and CEO of The David J. Joseph Company (DJJ), plans to retire effective September 12, 2014. According to the Company, Mr. Grass has served as CEO of DJJ since 2000 and was appointed Executive Vice President of Nucor when DJJ became part of Nucor in 2008. Nucor informed that upon the retirement of Keith, Joe Stratman, who has served as Nucor's Executive Vice President since 2007, will assume Executive Vice President responsibilities for the raw materials group, which, in addition to DJJ, includes Nucor's natural gas investments and logistics. The full research reports on Nucor are available to download free of charge at:
http://www.analystsreview.com/Aug-21-2014/NUE/report.pdf
Philip Morris International, Inc. Research Reports
On August 18, 2014, the stock of Philip Morris International, Inc. (Philip Morris) gained 0.58% to end the trading session at $84.99. After opening at $84.71, the stock fluctuated in the range of $84.63 - $85.10, with a total of 3.09 million shares changing hands. Over the last one month, the Company's stock has declined by 1.2%, compared to the Dow Jones Industrial Average which declined 1.53% during the same period. The full research reports on Philip Morris are available to download free of charge at:
http://www.analystsreview.com/Aug-21-2014/PM/report.pdf
Mondelez International, Inc. Research Reports
On August 6, 2014, Mondelez International, Inc. (Mondelez) announced its Q2 2014 financial results. The Company's net revenues during the quarter declined 1.85% YoY to $8.4 billion. Organic revenue was up 1.2% YoY, including a 3.6 percentage point impact from prices. Net income attributable to the Company in Q2 2014 was $622 million or $0.36 per diluted share, compared to $601 million or $0.33 per diluted share in Q2 2013. On an adjusted basis, Mondelez reported Q2 2014 diluted EPS of $0.40. According to Thomson Reuters, analysts on average, expected earnings of 39 cents. "We're making good progress on the strategic and cost-reduction actions we announced in May to strengthen our core snacking business, simplify our operations and enhance our margins. We delivered strong, high-quality operating margin expansion and EPS growth again this quarter in the face of a continuing challenging macroeconomic environment. Our revenue growth reflects this difficult global retail and consumer environment as well as a temporary dislocation related to our decision to lead the industry on pricing. Despite these challenges, we remain on track to achieve our margin and earnings commitments for the full year," said Mondelez Chairman and CEO, Irene Rosenfeld. The full research reports on Mondelez are available to download free of charge at:
http://www.analystsreview.com/Aug-21-2014/MDLZ/report.pdf
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
EDITOR'S NOTES:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
